Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)

NCT02608346 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT02608346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02608346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2014
Completion date
December 29, 2021
Enrollment
200 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

women with brca1 germline deleterious mutation